Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine.

Feng S, Melkersson K.

Neuro Endocrinol Lett. 2012;33(5):493-8.

PMID:
23090266
[PubMed - indexed for MEDLINE]
2.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28.

PMID:
15630069
[PubMed - indexed for MEDLINE]
3.

[Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].

Rubio G, Gómez-de-la-Cámara A, Ledesma F, Burón JA, Rodríguez-Morales A, Martínez-Junquera G; Grupo Español para el Estudio de la Diabetes en Pacientes Esquizofrénicos.

Med Clin (Barc). 2006 Apr 1;126(12):441-4. Spanish.

PMID:
16620729
[PubMed - indexed for MEDLINE]
4.

Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.

van Winkel R, De Hert M, Wampers M, Van Eyck D, Hanssens L, Scheen A, Peuskens J.

J Clin Psychiatry. 2008 Mar;69(3):472-9.

PMID:
18348593
[PubMed - indexed for MEDLINE]
5.

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.

Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.

J Clin Psychiatry. 2008 Feb;69(2):274-85.

PMID:
18232726
[PubMed - indexed for MEDLINE]
6.

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2003 Feb;160(2):290-6.

PMID:
12562575
[PubMed - indexed for MEDLINE]
7.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
8.

Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.

Melkersson K, Berinder K, Hulting AL.

Neuro Endocrinol Lett. 2011;32(4):428-36.

PMID:
21876517
[PubMed - indexed for MEDLINE]
9.

Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.

Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B.

Pharmacogenomics J. 2008 Jun;8(3):228-36. Epub 2007 Aug 28.

PMID:
17726453
[PubMed - indexed for MEDLINE]
10.

Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.

Melkersson KI, Dahl ML.

Psychopharmacology (Berl). 2003 Nov;170(2):157-66. Epub 2003 Jul 8.

PMID:
12851739
[PubMed - indexed for MEDLINE]
11.

Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.

Smith RC, Lindenmayer JP, Davis JM, Kelly E, Viviano TF, Cornwell J, Hu Q, Khan A, Vaidhyanathaswamy S.

J Clin Psychiatry. 2009 Nov;70(11):1501-13. doi: 10.4088/JCP.08m04446yel. Epub 2009 Oct 6.

PMID:
19814947
[PubMed - indexed for MEDLINE]
12.

Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.

Rosa F, Schreiner A, Thomas P, Sherif T.

Clin Drug Investig. 2012 Apr 1;32(4):267-79. doi: 10.2165/11599080-000000000-00000.

PMID:
22339430
[PubMed - indexed for MEDLINE]
13.

[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].

István S, Agoston T, Tamás T, Zoltán J.

Neuropsychopharmacol Hung. 2007 Oct;9(3):115-24. Hungarian.

PMID:
18399029
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.

Kluge M, Schuld A, Schacht A, Himmerich H, Dalal MA, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollmächer T.

Psychoneuroendocrinology. 2009 Jan;34(1):118-28. doi: 10.1016/j.psyneuen.2008.08.016. Epub 2008 Oct 4.

PMID:
18835660
[PubMed - indexed for MEDLINE]
15.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
16.
17.

Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.

Smith RC, Lindenmayer JP, Hu Q, Kelly E, Viviano TF, Cornwell J, Vaidhyanathaswamy S, Marcovina S, Davis JM.

Schizophr Res. 2010 Jul;120(1-3):204-9. doi: 10.1016/j.schres.2010.04.001. Epub 2010 May 10.

PMID:
20457512
[PubMed - indexed for MEDLINE]
18.

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.

Kluge M, Schuld A, Himmerich H, Dalal M, Schacht A, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollmächer T.

J Clin Psychopharmacol. 2007 Dec;27(6):662-6.

PMID:
18004133
[PubMed - indexed for MEDLINE]
19.

Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.

Gunes A, Melkersson KI, Scordo MG, Dahl ML.

J Clin Psychopharmacol. 2009 Feb;29(1):65-8. doi: 10.1097/JCP.0b013e31819302c3.

PMID:
19142110
[PubMed - indexed for MEDLINE]
20.

[Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].

Carpiniello B, Mellino G, Pintore S, Puddu L, Pinna F.

Clin Ter. 2011;162(4):331-41. Italian.

PMID:
21912821
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk